Table 3.
No. (%) | |||
---|---|---|---|
Cause of Allograft Failure | Eculizumab-Treated +XM Patients (n=8) | +XM Control Patients (n=21) | −XM Control Patients (n=8) |
Chronic antibody-mediated rejection | 8 (100) | 18 (85.7) | 1 (12.5) |
Nonadherence/acute rejection | 0 (0) | 0 (0) | 3 (37.5) |
Chronic volume depletion | 0 (0) | 0 (0) | 1 (12.5) |
Recurrent IgA nephropathy | 0 (0) | 1 (4.8) | 1 (12.5) |
Focal segmental glomerulosclerosis | 0 (0) | 1 (4.8) | 0 (0) |
Infection | 0 (0) | 0 (0) | 1 (12.5) |
Unknown | 0 (0) | 1 (4.8) | 1 (12.5) |
Abbreviations: IgA, immunoglobulin A; −XM, negative crossmatch; +XM, positive crossmatch.